Normally, I wouldn’t bother posting this, but there’s an impending issue: how will the dividend on the current Abbott be divided between the new Abbott and the drug spin-off, Abbvie? My supposition is that the new Abbott (#msg-75216470) will get 60-70% of it.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”